H.C. Wainwright Downgrades ZIOPHARM Oncology (ZIOP) to Neutral

March 1, 2021 6:10 AM EST
Get Alerts ZIOP Hot Sheet
Price: $3.35 --0%

Rating Summary:
    7 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 10 | New: 10
Trade Now! 
Join SI Premium – FREE

H.C. Wainwright analyst Swayampakula Ramakanth downgraded ZIOPHARM Oncology (NASDAQ: ZIOP) from Buy to Neutral.


For an analyst ratings summary and ratings history on ZIOPHARM Oncology click here. For more ratings news on ZIOPHARM Oncology click here.


Shares of ZIOPHARM Oncology closed at $5.33 yesterday.


You May Also Be Interested In





Related Categories

Downgrades